buprenorphine hcl

Generic: buprenorphine hcl

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name buprenorphine hcl
Generic Name buprenorphine hcl
Labeler camber pharmaceuticals, inc.
Dosage Form TABLET
Routes
SUBLINGUAL
Active Ingredients

buprenorphine hydrochloride 8 mg/1

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-871
Product ID 31722-871_80bd7b21-6679-4dbb-84dd-f755c7a90166
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA219401
DEA Schedule ciii
Listing Expiration 2027-12-31
Marketing Start 2026-01-12

Pharmacologic Class

Classes
partial opioid agonist [epc] partial opioid agonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722871
Hyphenated Format 31722-871

Supplemental Identifiers

RxCUI
351264 351265
UPC
0331722871303 0331722870306
UNII
56W8MW3EN1

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name buprenorphine hcl (source: ndc)
Generic Name buprenorphine hcl (source: ndc)
Application Number ANDA219401 (source: ndc)
Routes
SUBLINGUAL
source: ndc

Resolved Composition

Strengths
  • 8 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (31722-871-30)
source: ndc

Packages (1)

Ingredients (1)

buprenorphine hydrochloride (8 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBLINGUAL"], "spl_id": "80bd7b21-6679-4dbb-84dd-f755c7a90166", "openfda": {"upc": ["0331722871303", "0331722870306"], "unii": ["56W8MW3EN1"], "rxcui": ["351264", "351265"], "spl_set_id": ["b52cea0e-688f-4beb-bf7d-f228b81dbd23"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (31722-871-30)", "package_ndc": "31722-871-30", "marketing_start_date": "20260112"}], "brand_name": "Buprenorphine HCl", "product_id": "31722-871_80bd7b21-6679-4dbb-84dd-f755c7a90166", "dosage_form": "TABLET", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "31722-871", "dea_schedule": "CIII", "generic_name": "Buprenorphine HCl", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine HCl", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "8 mg/1"}], "application_number": "ANDA219401", "marketing_category": "ANDA", "marketing_start_date": "20260112", "listing_expiration_date": "20271231"}